-Reuters
VBL Therapeutics Announces Workforce Reduction
VBL Therapeutics (NASDAQ:VBLT), a biotechnology company developing targeted medicines for cancer and immune-inflammatory diseases, today announced an organizational streamlining designed to reduce operating expenses and